No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Healthcare Information Services
Oneview Healthcare PLC provides specialized software solutions and expert consulting services to the healthcare industry. Its market reach extends across Ireland, the United States, Australia, Asia, and the Middle East. The company's core offering is its Care Experience Platform (CXP), available in several configurations. CXP Cloud Start allows clients to implement vital digital engagement tools throughout their organizations. CXP Cloud Enterprise empowers patients and their families to communicate virtually with healthcare teams and access educational health resources. For on-premise requirements, CXP Enterprise On-Prem caters to diverse hospital environments, from newly constructed facilities to those with pre-existing legacy infrastructure. Additionally, Oneview Healthcare provides capabilities that include patient and family empowerment, streamlined patient experience management, virtual care delivery, and digital communication features such as door signs and patient communication boards. Founded in 2008, the company maintains its headquarters in Dublin, Ireland.
www.oneviewhealthcare.comNo one on the platform currently holds ONE.AX.
No tracked institution reports a position in ONE.AX as of their last filing.
No one on the platform has traded ONE.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| Rev. Growth % | 20.6% | 10.9% | ||||
| Profit Margin % | -104.9% | -103.1% | -176.2% | |||
| Free Cash Flow Margin % | -70.2% | -83.2% | -155.5% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $11M | -12.5% | $-0.01 | $-0.01–$-0.01 | — | 2 |
| 2027 | $14M | +28.9% | $-0.01 | $-0.01–$-0.01 | — | 2 |
| 2028 | $18M | +27.9% | $-0.01 | $-0.02–$0.01 | — | 2 |
| 2029 | $34M | +86.3% | $0.01 | $0.01–$0.01 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-26 | $-0.01 | $-0.02 | -66.6% |
| 2026-02-11 | $-0.01 | $-0.01 | +14.3% |
| 2025-08-01 | $-0.01 | $-0.02 | -75.4% |
| 2025-02-26 | $-0.01 | $-0.02 | -2.2% |
| 2024-08-29 | $-0.01 | $-0.02 | -25.1% |
| 2024-04-23 | $-0.01 | $-0.01 | +14.1% |
| 2024-02-27 | $-0.01 | $-0.01 | -16.6% |
| 2023-08-29 | $-0.02 |
| $-0.02 |
| +0.0% |
| -8.16% |
| $53M |
| — |
| PAR.AXParadigm Biopharmaceuticals Limited | $0.25 | +4.17% | $150M | — |
| PCK.AXPainChek Limited | $0.12 | +0.00% | $24M | — |
Source: Financial Modeling Prep · peers by sector/industry